Panagiotis Repousis

965 total citations
28 papers, 451 citations indexed

About

Panagiotis Repousis is a scholar working on Hematology, Oncology and Molecular Biology. According to data from OpenAlex, Panagiotis Repousis has authored 28 papers receiving a total of 451 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Hematology, 15 papers in Oncology and 13 papers in Molecular Biology. Recurrent topics in Panagiotis Repousis's work include Multiple Myeloma Research and Treatments (14 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (6 papers) and Amyloidosis: Diagnosis, Treatment, Outcomes (6 papers). Panagiotis Repousis is often cited by papers focused on Multiple Myeloma Research and Treatments (14 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (6 papers) and Amyloidosis: Diagnosis, Treatment, Outcomes (6 papers). Panagiotis Repousis collaborates with scholars based in Greece, United States and Cyprus. Panagiotis Repousis's co-authors include Meletios Α. Dimopoulos, Evangelos Terpos, Efstathios Kastritis, Marie‐Christine Kyrtsonis, Argiris Symeonidis, Eirini Katodritou, Sosana Delimpasi, Anastasia Pouli, Dimitra Gika and Zafiris Kartasis and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Stroke.

In The Last Decade

Panagiotis Repousis

25 papers receiving 444 citations

Peers

Countries citing papers authored by Panagiotis Repousis

Since Specialization

Citations

This map shows the geographic impact of Panagiotis Repousis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Panagiotis Repousis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Panagiotis Repousis more than expected).

Fields of papers citing papers by Panagiotis Repousis

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Panagiotis Repousis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Panagiotis Repousis. The network helps show where Panagiotis Repousis may publish in the future.

Co-authorship network of co-authors of Panagiotis Repousis

This figure shows the co-authorship network connecting the top 25 collaborators of Panagiotis Repousis. A scholar is included among the top collaborators of Panagiotis Repousis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Panagiotis Repousis. Panagiotis Repousis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Effectiveness of 5-Azacytidine in older patients with high-risk myelodysplastic syndromes and oligoblastic acute myeloid leukemia: A retrospective analysis of the Hellenic (Greek) MDS Study Group 2019 ·Journal of Geriatric Oncology ·Sotirios G. Papageorgiou, Christos K. Kontos, Ιoannis Kotsianidis, Paraskevi Karousi, Argiris Symeonidis, Athanasios Galanopoulos, (unknown), Eleftheria Hatzimichael, Panagiotis Repousis, Panagiotis Zikos, Nora‐Athina Viniou, (unknown), Theodoros P. Vassilakopoulos, Panagiotis Diamantopoulos, (unknown), (unknown), Helen Α. Papadaki, Panayiotis Panayiotidis, Vasiliki Pappa	4
2	The outcome of patients with high‐risk MDS achieving stable disease after treatment with 5‐azacytidine: A retrospective analysis of the Hellenic (Greek) MDS Study Group 2018 ·Hematological Oncology ·Sotirios G. Papageorgiou, Christos K. Kontos, Ιoannis Kotsianidis, Diamantina Vasilatou, Argiris Symeonidis, Athanasios Galanopoulos, (unknown), Eleftheria Hatzimichael, Panagiotis Repousis, Panagiotis Zikos, Nora‐Athina Viniou, (unknown), Theodoros P. Vassilakopoulos, Panagiotis Diamantopoulos, (unknown), (unknown), (unknown), Helen Α. Papadaki, Panayiotis Panayiotidis, Vasiliki Pappa	7
3	Real-World data for the Treatment of Relapsed/Refractory Multiple Myeloma with Lenalidomide and Dexamethasone in 2nd Line (Legend Study): The Prognostic Significance of Biochemical Versus Clinical Relapse 2017 ·Clinical Lymphoma Myeloma & Leukemia ·Eirini Katodritou, Sossana Delimpasi, (unknown), (unknown), Argiris Symeonidis, Emmanouil Spanoudakis, (unknown), Αchilles Anagnostopoulos, Anna Kioumi, Panagiotis Zikos, (unknown), (unknown), (unknown), Maria Kotsopoulou, Panagiotis Repousis, Ioannis Adamopoulos, (unknown), (unknown), Helen Α. Papadaki, Evangelos Terpos	0
4	Primary bone lymphoma (PBL) real world experience of a single cancer hospital. results, prognostic factors, treatment and long term follow up of 12 patients. 2017 ·Journal of Clinical Oncology ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Panagiotis Repousis, Maria Kotsopoulou	0
5	The Management and Costs of Multiple Myeloma in Greece: Mapping the Local Treatment Pathway and Associated Resource Use 2016 ·Value in Health ·Όλγα Σίσκου, (unknown), Sosana Delimpasi, Eirini Katodritou, (unknown), Anastasia Pouli, Panagiotis Repousis, Evangelos Terpos, (unknown), (unknown), Olympia Konstantakopoulou, Ilias Goranitis, (unknown), Meletios Α. Dimopoulos	0
6	Significance of the detection of paroxysmal nocturnal hemoglobinuria clones in patients with multiple myeloma undergoing autologous stem cell transplantation 2015 ·Hematology/Oncology and Stem Cell Therapy ·(unknown), (unknown), Kostas Konstantopoulos, Panagiotis Repousis, (unknown), Maria Kotsopoulou, (unknown), Theodoros P. Vassilakopoulos, Maria K. Angelopoulou	7
7	Significant improvement in the survival of patients with multiple myeloma presenting with severe renal impairment after the introduction of novel agents 2013 ·Annals of Oncology ·Meletios Α. Dimopoulos, Sosana Delimpasi, Eirini Katodritou, Amalia Vassou, Maria‐Christina Kyrtsonis, Panagiotis Repousis, Zafiris Kartasis, Agapi Parcharidou, Michalis Michael, Eurydiki Michalis, Dimitra Gika, Argiris Symeonidis, Anastasia Pouli, Kostas Konstantopoulos, Evangelos Terpos, Efstathios Kastritis	109
8	IgD Myeloma: Clinical Features and Outcome In The Era Of Novel Agents 2013 ·Blood ·Flora Zagouri, Efstathios Kastritis, Argiris Symeonidis, Nikolaos Giannakoulas, Eirini Katodritou, Sosana Delimpasi, Panagiotis Repousis, Stavroula Giannouli, (unknown), Evangelos Terpos, Meletios Α. Dimopoulos	1
9	Immunoglobulin D myeloma: clinical features and outcome in the era of novel agents 2013 ·European Journal Of Haematology ·Flora Zagouri, Efstathios Kastritis, Argiris Symeonidis, Nikolaos Giannakoulas, Eirini Katodritou, Sosana Delimpasi, Panagiotis Repousis, Evangelos Terpos, Meletios Α. Dimopoulos, (unknown)	24
10	Re‐evaluation of prognostic markers including staging, serum free light chains or their ratio and serum lactate dehydrogenase in multiple myeloma patients receiving novel agents 2012 ·Hematological Oncology ·(unknown), Meletios Α. Dimopoulos, (unknown), Panagiotis Repousis, Anastasia Pouli, Evangelos Terpos, Panayiotis Panayiotidis, Sossana Delimpasi, Evridiki Michalis, Konstantinos Anargyrou, Maria Gavriatopoulou, (unknown), Τατιάνα Τζένου, Efstathios Koulieris, (unknown), Maria Dimou, Theodoros P. Vassilakopoulos, Maria K. Angelopoulou, Gerassimos A. Pangalis, Marie‐Christine Kyrtsonis	50
11	Outcomes of Hodgkin’s Lymphoma Patients with Relapse or Progression following Autologous Hematopoietic Cell Transplantation 2011 ·Biology of Blood and Marrow Transplantation ·Panayotis Kaloyannidis, (unknown), Ioannis Baltadakis, Panagiotis Tsirigotis, Alexandros Spyridonidis, Panagiotis Repousis, (unknown), (unknown), Dimitrios Karakasis, Ioanna Sakellari, (unknown), (unknown), Αchilles Anagnostopoulos	22
12	Osteonecrosis of the jaw in oncology patients treated with bisphosphonates: prospective experience of a dental oncology referral center 2011 ·Oral Surgery Oral Medicine Oral Pathology Oral Radiology and Endodontology ·Ourania Nicolatou‐Galitis, Erofili Papadopoulou, (unknown), (unknown), (unknown), Marie‐Christine Kyrtsonis, Panagiotis Repousis, (unknown), César A. Migliorati	60
13	High levels of serum angiogenic growth factors in patients with AL amyloidosis: comparisons with normal individuals and multiple myeloma patients 2010 ·British Journal of Haematology ·Efstathios Kastritis, Μαρία Ρούσσου, Michalis Michael, Maria Gavriatopoulou, Evridiki Michalis, Magdalini Migkou, Sossana Delimpasi, (unknown), (unknown), Konstantinos Liapis, (unknown), Panagiotis Repousis, Evangelos Terpos, Meletios Α. Dimopoulos, (unknown)	9
14	Hematologic Toxicity in Patients Treated with Sunitinib for Advanced Thyroid Cancer 2010 ·Thyroid ·(unknown), (unknown), (unknown), Panagiotis Repousis, Nikolaos Ziras, (unknown)	12
15	High dose chemotherapy and autologous stem cell transplantation in patients with multiple myeloma: the experience of a single haematological unit. 2008 ·PubMed ·(unknown), (unknown), Panagiotis Repousis, (unknown), (unknown), (unknown), Maria Kotsopoulou, (unknown)	2
16	Prevalence of autoantibodies (ANA, anti ds-DNA, ENA, IMF) and rheumatic syndromes in patients with lymphoproliferative diseases. 2007 ·PubMed ·(unknown), (unknown), Panagiotis Repousis, (unknown), (unknown), Dimitrios T. Trafalis, (unknown), (unknown)	7
17	Dexamethasone, cyclophosphamide, etoposide and cisplatin (DCEP) for relapsed or refractory multiple myeloma patients. 2007 ·PubMed ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Panagiotis Repousis, (unknown)	23
18	Epoetin beta (NeoRecormon) corrects anaemia in patients with hormone-refractory prostate cancer and bone metastases. 2004 ·PubMed ·John Bogdanos, Dimitrios Karamanolakis, (unknown), Panagiotis Repousis, (unknown), (unknown), (unknown), (unknown), M. Koutsilieris	20
19	Chronic myelogenous leukemia terminating in acute megakaryoblastic leukemia. Case report. 1998 ·PubMed ·(unknown), Panagiotis Repousis, Stavroula Tsiara, Leonidas Christou, Pavlina Konstantinidou, Mei Bai	7
20	Combination Therapy with Recombinant Human Erythropoietin, Interferon-α-2b and Granulocyte- Macrophage Colony-Stimulating Factor in Idiopathic Myelofibrosis 1996 ·Acta Haematologica ·Konstantinos L. Bourantas, Stavroula Tsiara, Leonidas Christou, Panagiotis Repousis, Pavlina Konstantinidou, (unknown), (unknown)	14

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact